Characteristics and management of diabetic patients hospitalized for myocardial infarction in France

Diabetes and Metabolism

Volumn 36, Issue 2, 2010, Pages 129-136

  Tuppin, P ^a   Neumann, A ^a   Simon, D ^b   Weill, A ^a   de Peretti, C ^c   Danchin, N ^d   Ricordeau, P ^a   Allemand, H ^a  

^a Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Diabetes; Epidemiology; France; Hospitalization; Myocardial Infarction; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOTONIC AGENT; CARDIOVASCULAR AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRIC ACID DERIVATIVE; VASODILATOR AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FRANCE; HEART INFARCTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; STENT;

EID: 77953468207     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2009.10.003     Document Type: Article

References (34)

1. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
2. Hu F.B., Stampfer M.J., Solomon C.G., Willett W.C., Speizer F.E., Nathan D.M., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161 (2001) 1717-1723
3. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 (1993) 434-444
4. Mukamal K.J., Nesto R.W., Cohen M.C., Muller J.E., Maclure M., Sherwood J.B., et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 4 (2001) 1422-1427
5. Koek H.L., Soedamah-Muthu S.S., Kardaun J.W., Gevers E., de Bruin A., Reitsma J.B., et al. Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus. Eur J Epidemiol 22 (2007) 883-888
6. Norhammar A., Lindbäck J., Rydén L., Wallentin L., and Stenestrand U. Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA).Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart 93 (2007) 1577-1583
7. Briffa T., Hickling S., Knuiman M., Hobbs M., Hung J., Sanfilippo F.M., et al. Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005. BMJ 338 (2009 Jan 26) b36
8. Genès N., Vaur L., Dubroca I., Etienne S., Cambou J.P., and Danchin N. Prognosis after myocardial infarct in a diabetic patient: results of coronary intensive care unit epidemiological study. Presse Med 27 (1998) 1003-1008
9. Bouraoui H., Trimeche B., Ernez-Hajri S., Mahdhaoui A., Zaaraoui J., Gasmi A., et al. Impact of diabetes on mortality after myocardial infarction. Ann Cardiol Angeiol (Paris) 54 (2005) 55-59
10. Vaur L., Danchin N., Hanania G., Cambou J.P., Lablanche J.M., Blanchard D., et al. Management and short-term outcome of diabetic patients hospitalized for acute myocardial infarction: results of a nationwide French survey. Diabetes Metab 29 (2003) 241-249
11. Müller-Nordhorn J., Binting S., Roll S., and Willich S.N. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 29 (2008) 1316-1326
12. Arveiler D., Wagner A., Ducimetière P., Montaye M., Ruidavets J.B., Bingham A., et al. Trends in coronary heart disease in France during the second half of the 1990s. Eur J Cardiovasc Prev Rehabil 12 (2005) 209-215
13. Booth G.L., Kapral M.K., Fung K., and Tu J.V. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29 (2006) 32-37
14. Fox C.S., Coady S., Sorlie P.D., Levy D., Meigs J.B., D'Agostino Sr. R.B., et al. Trends in cardiovascular complications of diabetes. JAMA 292 (2004) 2495-2499
15. Bottle A., Millett C., Khunti K., and Majeed A. Trends in cardiovascular admissions and procedures for people with and without diabetes in England, 1996-2005. Diabetologia 52 (2009) 74-80
16. Detre K.M., Guo P., Holubkov R., Califf R.M., Sopko G., Bach R., et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 99 (1999) 633-640
17. Yan R.T., Yan A.T., Tan M., McGuire D.K., Leiter L., Fitchett D.H., et al. Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes. Am Heart J 152 (2006) 676-683
18. Natali A., Vichi S., Landi P., Severi S., L'Abbate A., and Ferrannini E. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia 43 (2004) 632-641
19. Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
20. Tarantini G., Ramondo A., Napodano M., Favaretto E., Gardin A., Bilato C., et al. PCI versus CABG for multivessel coronary disease in diabetics. Catheter Cardiovasc Interv 73 (2009) 50-58
21. Daemen J., Kuck K.H., Macaya C., LeGrand V., Vrolix M., Carrie D., et al. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol 52 (2008) 1957-1967
22. Hlatky M.A., and Bravata D.M. Stents or surgery? New data on the comparative outcomes of percutaneous coronary intervention and coronary artery bypass graft surgery. Circulation 118 (2008) 325-327
23. Javaid A., Steinberg D.H., Buch A.N., Buch A.N., Corso P.J., Boyce S.W., et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 116 (2007) 1200-1206
24. Hlatky M.A., Boothroyd D.B., Bravata D.M., Boersma E., Booth J., Brooks M.M., et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373 (2009) 1190-1197
25. Malmberg K., Rydén L., Efendic S., Herlitz J., Nicol P., Waldenström A., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
26. Anselmino M., Ohrvik J., Malmberg K., Standl E., Rydén L., and Euro Heart Survey Investigators. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart. Eur Heart J 29 (2008) 177-184
27. Mellbin L.G., Malmberg K., Waldenström A., Wedel H., and Rydén L. Prognostic implications of hypoglycemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes. A report from the DIGAMI 2 trial. Heart 95 (2009) 721-727
28. Malmberg K., Rydén L., Wedel H., Birkeland K., Bootsma A., Dickstein K., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
29. Radke P.W., and Schunkert H. Glucose-lowering therapy after myocardial infarction: more questions than answers. Eur Heart J 29 (2008) 141-143
30. Bringer J., Fontaine P., Detournay B., Nachit-Ouinekh F., Brami G., and Eschwege E. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: The INSTANT study. Diabetes Metab 35 (2009) 25-31
31. Kusnik-Joinville O., Weill A., Salanave B., Ricordeau P., and Allemand H. Prevalence and treatment of diabetes in France: trends between 2000 and 2005. Diabetes Metab 34 (2008) 266-272
32. Forouhi N.G., Merrick D., Goyder E., Ferguson B.A., Abbas J., Lachowycz K., et al. Diabetes prevalence in England, 2001--estimates from an epidemiological model. Diabetes Med 23 (2006) 189-197
33. Romon I., Fosse S., Eschwège E., Simon D., Weill A., Varroud-Vial M., et al. Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France: the ENTRED study 2001. Diabetes Metab 34 (2008) 140-147
34. Tuppin P., Neumann A., Danchin N., Weill A., Ricordeau P., de Peretti C., et al. Combined secondary prevention after hospitalisation for myocardial infarction in France: an analysis from a large administrative database. Arch Cardiovasc Dis 102 (2009) 279-292